Commentary: The high price of insulin creates obscene profits for drugmakers

(Darron Cummings | The Associated Press) This April 26, 2017, file photo shows the Eli Lilly & Co. corporate headquarters in Indianapolis.

(Darron Cummings | The Associated Press) This April 26, 2017, file photo shows the Eli Lilly & Co. corporate headquarters in Indianapolis.

RELATED STORIES

Commentary: Time for Mitt Romney to practice what he preaches

Commentary: America, don’t get used to it!

Commentary: Revoke my security clearance, too, Mr. President

Commentary: U.S. needs a Space Force and a Cyber Force

Commentary: Future physician backs Proposition 3

MOST VIEWED

1

Becoming Catholic: I went from an ‘emphasis on obedience’ to a ‘state of grace,’ says former Latter-day Saint

2

Data centers got tax breaks. Homeowners were asked to pay triple. Here’s how Eagle Mountain’s tax fight shook out.

3

After a decade in SLC’s Central 9th, this restaurant says it’s being forced to leave. Here’s what’s next.

4

Qualtrics lays off employees in Utah and across the globe after $6.75B acquisition

5

LDS students at Dallin Oaks’ alma mater tackle LGBTQ+ issues, gender and more in new journal

Sponsored Story

Don’t let fraud and scams ground your summer vacation

Sponsored: While even the most prepared consumers can fall victim to a well-executed scam, remember these tips to protect your vacation plans.

By Luke Dalton | For The Tribune